The Y rolls out new health program targeting diabetes

NewsGuard 100/100 Score

YMCAs will advance the program nationally with support from insurers and employers. Also in the news, researchers express concern about the increasing costs likely to accompany soaring Alzheimer's disease rates.

The Wall Street Journal: The Y Takes On Diabetes
A new health program being rolled out at YMCAs across the country shows the potential for a community-based organization to deliver a nationwide health care intervention. The Y's target is diabetes. Research has shown that the program, which combines exercise, dieting and individual counseling, can have a big impact in reducing incidences of diabetes. Impressed by the research, insurers and employers are providing direct funding as the YMCA seeks to enroll participants in the program and induce them to reach weight-loss targets (Dooren, 2/14).

USA Today: As Alzheimer's Rate Soars, Concern Rises Over Costs
Patients with Alzheimer's and other forms of dementia will spend three times more on health care than patients with other types of illnesses, the association says. Medicare patients with Alzheimer's and other dementias spent $43,847 on health care and long-term care services, compared to $13,879 spent by patients without those illnesses, the association said in a 2012 report. For government health care programs already facing economic strain, these estimates are daunting, researchers and advocates say (Lloyd, 2/14).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Experimental monoclonal antibody prevents and reverses clinical type 1 diabetes in mice